Article

Predicting Parkinson’s Disease Medication Regimen Using Sensor Technology

2021-02-18

Abstract excerpt

Parkinson’s disease (PD) medication treatment planning is generally based on subjective data through in-office, physicianpatient interactions. The Personal KinetiGraphTM (PKG) has shown promise in enabling objective, continuous remote health monitoring for Parkinson’s patients. In this proof-of-concept study, we propose to use objective sensor data from the PKG and apply machine learning to subtype patients based...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7e609870-64ac-523d-8efb-62bc8c8f0d52
DOI: 10.21203/rs.3.rs-198765/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting Parkinson’s Disease Medication Regimen Using Sensor TechnologyDOI 10.21203/rs.3.rs-198765/v1Read

Identification of kinematic biomarkers for self-reported Parkinson's disease symptomsSemantic proximity Read

From Clinical Criteria to AI-Based Classification of Advanced Parkinson’s Disease: A Data-Driven Approach Using Structured PPMI DataSemantic proximity Read

Artificial Intelligence-Based Clustering and Characterization of Parkinson’s Disease TrajectoriesSemantic proximity Read

Artificial intelligence-based clustering and characterization of Parkinson's disease trajectoriesSemantic proximity Read

Wearable devices can identify Parkinson’s disease up to 7 years before clinical diagnosisSemantic proximity Read

Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clusteringSemantic proximity Read

Integrated Genetic, Molecular, and Wearable Sensor Biomarkers Enable Bayesian Machine Learning-Driven Precision Stratification in Parkinson’s Disease: A Comprehensive Multi-Cohort Validation StudySemantic proximity Read

Patient Questionnaires Based Parkinson’s Disease Classification Using Artificial Neural NetworkSemantic proximity Read

AccessPD - a ‘next generation’ registry to accelerate Parkinson’s disease researchSemantic proximity Read

Levodopa-related physiomarkers during deep brain stimulation in Parkinson’s diseaseSemantic proximity Read

Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol StudySemantic proximity Read

Ai-Augmented Management of Pharmacoresistant Insomnia and Restless Legs Syndrome in Park2 Parkinson’s Disease: an N-Of-1 Case Report Integrating Pharmacogenetics, Chronopharmacology, Digital Monitoring, and an Llm Co-PilotSemantic proximity Read